nimodipine has been researched along with Smoking Cessation in 1 studies
Nimodipine: A calcium channel blockader with preferential cerebrovascular activity. It has marked cerebrovascular dilating effects and lowers blood pressure.
nimodipine : A dihydropyridine that is 1,4-dihydropyridine which is substituted by methyl groups at positions 2 and 6, a (2-methoxyethoxy)carbonyl group at position 3, a m-nitrophenyl group at position 4, and an isopropoxycarbonyl group at position 5. An L-type calcium channel blocker, it acts particularly on cerebral circulation, and is used both orally and intravenously for the prevention and treatment of subarachnoid hemorrhage from ruptured intracranial aneurysm.
Smoking Cessation: Discontinuing the habit of SMOKING.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| De la Torre-Colmenero, JD | 1 |
| Arjona-Padillo, A | 1 |
| Fernandez-Perez, J | 1 |
1 other study available for nimodipine and Smoking Cessation
| Article | Year |
|---|---|
[Reversible cerebral vasoconstriction syndrome following smoking cessation and treatment with bupropion].
Topics: Apraxias; Bupropion; Calcium Channel Blockers; Carotid Stenosis; Cerebral Arteries; Cerebrovascular | 2018 |